Product Information

LISDEXAMFETAMINE 20 MG TB CHEW is a generic product labeled by Camber Pharmaceuticals Inc., priced at $4.3927 per EA under NDC 31722032201. Its NADAC has been published 85 times since Jan 8, 2025.

FDA first approved this application on Aug 25, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LISDEXAMFETAMINE 20 MG TB CHEW

lisdexamfetamine dimesylate
$4.3927per EA
DEA Schedule CII

Strength

20 mg/1

NDC

31722032201

Classification

Generic

Dosage Form

TABLET, CHEWABLE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA217068

FDA Approved

8/25/2023

TE Code

AB

On Market Since

8/25/2023

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for LISDEXAMFETAMINE 20 MG TB CHEW has been published 85 times since Jan 8, 2025, and over the history we have for it it has declined 43.2%. The table below summarizes its recorded NADAC range and movement.

Current price$4.3927 per EA
All-time high$8.3615 (May 14, 2025)
All-time low$4.2936 (Jul 22, 2026)
52-week high$7.1531
52-week low$4.2936
Median price$6.2661
Average price$6.3491
Largest weekly change-13.0% (Feb 18, 2026)
Weeks tracked85
Tracking sinceJan 8, 2025

Price History

1W

+2.3%

1M

+2.3%

3M

+1.1%

6M

-10.5%

1Y

-38.6%

3Y

N/A

5Y

N/A

All

-43.2%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LISDEXAMFETAMINE 20 MG TB CHEW?

The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 20 MG TB CHEW, manufactured by Camber Pharmaceuticals Inc., is $4.3927 per EA (NDC 31722032201), effective Aug 19, 2026.

How has the price of LISDEXAMFETAMINE 20 MG TB CHEW changed over time?

Over the history we have for it, the NADAC for LISDEXAMFETAMINE 20 MG TB CHEW has declined 43.2%. It has been tracked across 85 weekly CMS publications since Jan 8, 2025.

What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 20 MG TB CHEW?

Since Jan 8, 2025, the NADAC for LISDEXAMFETAMINE 20 MG TB CHEW has ranged from a low of $4.2936 (Jul 22, 2026) to a high of $8.3615 (May 14, 2025), with a median of $6.2661 per EA.

Are there cheaper alternatives to LISDEXAMFETAMINE 20 MG TB CHEW?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LISDEXAMFETAMINE 20 MG TB CHEW in a comparable dosage form, but none are currently priced below it.

Who manufactures LISDEXAMFETAMINE 20 MG TB CHEW?

LISDEXAMFETAMINE 20 MG TB CHEW (NDC 31722032201) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.